Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2020 Filed Jan 7, 2020 23:12 UTC |
Pellizzari Christine AChief Legal Officer
|
GrantCommon Stock | 26,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000025 · edgar.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,658 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,789 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 56,520 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001127430-20-000026 · edgar.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,520 Underlying: Common Stock · 56,520 shares Expires 2030-01-03 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Tax withholdingCommon Stock | 979 | $23.75 | $23,251.25 |
DisclosureSEC source: 0001127430-20-000026 · edgar.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,552 F4 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:13 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 10,526 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000026 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,531 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,655 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:12 UTC |
Lewis WilliamDirector · Chairman and CEO
|
GrantStock Option (right to buy) · Derivative | 282,590 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001127430-20-000024 · edgar.xml · derivative · entry 2 Lewis William · CIK 0001402051 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,590 Underlying: Common Stock · 282,590 shares Expires 2030-01-03 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:12 UTC |
Lewis WilliamDirector · Chairman and CEO
|
GrantCommon Stock | 52,631 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000024 · edgar.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,092 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,789 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:05 UTC |
Adsett RogerChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 141,300 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001127430-20-000021 · edgar.xml · derivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,300 Underlying: Common Stock · 141,300 shares Expires 2030-01-03 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:05 UTC |
Adsett RogerChief Operating Officer
|
Tax withholdingCommon Stock | 1,414 | $23.75 | $33,582.50 |
DisclosureSEC source: 0001127430-20-000021 · edgar.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,721 F3 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:05 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 26,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000021 · edgar.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,135 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:09 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 56,520 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001127430-20-000022 · edgar.xml · derivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,520 Underlying: Common Stock · 56,520 shares Expires 2030-01-03 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:09 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 10,526 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000022 · edgar.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,526 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years. F2 · price: Each Restricted Stock Unit was granted on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 150,990 | $0.00 Strike: $23.66 | $0.00 |
DisclosureSEC source: 0001127430-20-000007 · edgar.xml · derivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,990 Underlying: Common Stock · 150,990 shares Expires 2030-01-02 F1 · derivative.exercise_date: In connection with the appointment of Dr. Flammer as the Company's Chief Medical Officer, the Company granted Dr. Flammer an option to purchase a total of 150,990 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Dr. Flammer's continued employment with the Company on each vesting date. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:12 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 24,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000133 · edgar.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,820 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: 100% on the third anniversary of the date of grant. F2 · price: Each Restricted Stock Unit was granted on November 18, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,789 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended July 31, 2019. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:10 UTC |
GOLL JOHNChief Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.58 | $0.00 |
DisclosureSEC source: 0001127430-19-000131 · edgar.xml · derivative · entry 3 GOLL JOHN · CIK 0001779466 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. These stock options are currently exercisable Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:10 UTC |
GOLL JOHNChief Accounting Officer
|
SaleStock Option | 25,000 | $20.04 | $501,000.00 |
DisclosureSEC source: 0001127430-19-000131 · edgar.xml · nonDerivative · entry 2 GOLL JOHN · CIK 0001779466 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,322 F1 · price: This is the weighted average sales price representing 25,000 shares sold at prices ranging from $19.75 to $20.20 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:10 UTC |
GOLL JOHNChief Accounting Officer
|
Exercise / conversionStock Option | 25,000 | $12.58 | $314,500.00 |
DisclosureSEC source: 0001127430-19-000131 · edgar.xml · nonDerivative · entry 1 GOLL JOHN · CIK 0001779466 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:15 UTC |
Desjardins ClarissaDirector
|
GrantCommon Stock | 5,295 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000120 · edgar.xml · nonDerivative · entry 1 Desjardins Clarissa · CIK 0001793390 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on November 12, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| June 25, 2019 Filed Jun 25, 2019 20:06 UTC |
Lewis WilliamDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 277,684 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001127430-19-000094 · edgar.xml · derivative · entry 3 Lewis William · CIK 0001402051 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,630 Underlying: Common Stock · 277,684 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options are currently exercisable. Read SEC document |
| June 25, 2019 Filed Jun 25, 2019 20:06 UTC |
Lewis WilliamDirector · Chairman, President & CEO
|
SaleCommon Stock | 400,000 | $26.00 | $10,400,000.00 |
DisclosureSEC source: 0001127430-19-000094 · edgar.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,672 F1 · shares: The reporting person sold the shares following the underwriter's exercise of an overallotment option in connection with a public offering by the issuer. Read SEC document |
| June 25, 2019 Filed Jun 25, 2019 20:06 UTC |
Lewis WilliamDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 277,684 | $26.00 | $7,219,784.00 |
DisclosureSEC source: 0001127430-19-000094 · edgar.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 20:50 UTC Amendment |
Lewis WilliamDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 277,684 | $3.40 | $944,125.60 |
DisclosureSEC source: 0001127430-19-000100 · edgar.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was inadvertently reported incorrectly on the original Form 4. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:05 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001127430-19-000083 · edgar.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,226 Underlying: Common Stock · 12,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Incentive Plan. These stock options are currently exercisable. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:05 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleStock Option | 12,000 | $23.24 | $278,839.20 |
DisclosureSEC source: 0001127430-19-000083 · edgar.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,350 F1 · price: This is the weighted average sales price representing 12,000 shares sold at prices ranging from $23.00 to $23.66 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:05 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionStock Option | 12,000 | $6.96 | $83,520.00 |
DisclosureSEC source: 0001127430-19-000083 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:17 UTC |
LEE LEODirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000077 · edgar.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,965 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:18 UTC |
SHAROKY MELVIN MDDirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000079 · edgar.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,693 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:17 UTC |
ENGELSEN STEINAR JDirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000076 · edgar.xml · nonDerivative · entry 1 ENGELSEN STEINAR J · CIK 0001218860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,202 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:18 UTC |
MCGIRR DAVID W JDirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000078 · edgar.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,261 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:16 UTC |
Brennan David RDirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000075 · edgar.xml · nonDerivative · entry 1 Brennan David R · CIK 0001609305 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,221 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:16 UTC |
ANDERSON ELIZABETH MDirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000074 · edgar.xml · nonDerivative · entry 1 ANDERSON ELIZABETH M · CIK 0001758247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,017 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:15 UTC |
ALTOMARI ALFREDDirector
|
GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000073 · edgar.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,841 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:15 UTC |
SORIANO JOHNChief Compliance Officer
|
GrantCommon Stock | 12,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000072 · edgar.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,892 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 957 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:14 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 14,660 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000071 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,350 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:12 UTC |
Adsett RogerChief Commercial Officer
|
GrantCommon Stock | 21,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000068 · edgar.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,168 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,015 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:13 UTC |
Pellizzari Christine AChief Legal Officer
|
GrantCommon Stock | 25,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000070 · edgar.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,554 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,015 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:13 UTC |
Lewis WilliamDirector · President & CEO
|
GrantCommon Stock | 51,741 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000069 · edgar.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,988 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 20:06 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,286 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001127430-19-000045 · edgar.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 6,286 shares Expires 2021-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 20:06 UTC |
HAYDEN DONALD J JRDirector
|
SaleCommon Stock | 6,286 | $32.99 | $207,375.14 |
DisclosureSEC source: 0001127430-19-000045 · edgar.xml · nonDerivative · entry 2 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,197 F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 20:06 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionCommon Stock | 6,286 | $3.03 | $19,046.58 |
DisclosureSEC source: 0001127430-19-000045 · edgar.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 21:07 UTC |
ALTOMARI ALFREDDirector
|
SaleCommon Stock | 5,500 | $30.00 | $165,000.00 |
DisclosureSEC source: 0001127430-19-000040 · edgar.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,942 F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 21:07 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,900 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001127430-19-000035 · edgar.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Underlying: Common Stock · 14,900 shares Expires 2021-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 21:07 UTC |
HAYDEN DONALD J JRDirector
|
SaleCommon Stock | 14,900 | $28.08 | $418,392.00 |
DisclosureSEC source: 0001127430-19-000035 · edgar.xml · nonDerivative · entry 2 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,197 F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 21:07 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionCommon Stock | 14,900 | $3.03 | $45,147.00 |
DisclosureSEC source: 0001127430-19-000035 · edgar.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:05 UTC |
ALTOMARI ALFREDDirector
|
SaleCommon Stock | 5,500 | $27.50 | $151,250.00 |
DisclosureSEC source: 0001127430-19-000032 · edgar.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,442 F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 15, 2019 Filed Feb 27, 2019 21:08 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001127430-19-000041 · edgar.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 100 shares Expires 2021-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant. F3 · balance_after: Total does not reflect previously reported transactions that occurred after February 15, 2019. This report has been filed late due to a broker reporting error. Read SEC document |
| February 15, 2019 Filed Feb 27, 2019 21:08 UTC |
HAYDEN DONALD J JRDirector
|
SaleCommon Stock | 100 | $27.90 | $2,790.00 |
DisclosureSEC source: 0001127430-19-000041 · edgar.xml · nonDerivative · entry 2 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,197 F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 15, 2019 Filed Feb 27, 2019 21:08 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionCommon Stock | 100 | $3.03 | $303.00 |
DisclosureSEC source: 0001127430-19-000041 · edgar.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:07 UTC |
ALTOMARI ALFREDDirector
|
SaleCommon Stock | 5,500 | $25.00 | $137,500.00 |
DisclosureSEC source: 0001127430-19-000029 · edgar.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,942 F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:15 UTC |
ALTOMARI ALFREDDirector
|
SaleCommon Stock | 5,500 | $22.50 | $123,750.00 |
DisclosureSEC source: 0001127430-19-000025 · edgar.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,442 F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 04, 2019 Filed Jan 7, 2019 21:10 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Tax withholdingCommon Stock | 979 | $14.85 | $14,538.15 |
DisclosureSEC source: 0001127430-19-000020 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,690 F1 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.